药物遗传学可能会预防自闭症谱系障碍的心理不良事件:一项观察性试点研究
Laura de Miguel1,2, Pura Ballester3, Cecilia Egoavil1,4
1Pharmacogenetic Unit, Clinical Pharmacology Department, Alicante Institute for Health and Biomedical Research (ISABIAL), General University Hospital of Alicante, c/Pintor Baeza, 12, 03010 Alicante, Spain.
Pharmaceuticals (Basel, Switzerland)
|October 28, 2023
概括
像DOP2这样的药物遗传标记可能有助于预防自闭症谱系障碍 (ASD) 和智力障碍 (ID) 患者的不良药物事件. 需要进一步的研究来证实这些发现,以获得更安全的处方.
科学领域:
- 药物遗传学 药物遗传学
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 在自闭症谱系障碍 (ASD) 和智力障碍 (ID) 患者中,精神药物处方的高患病率高达73%.
- 在这个人群中,常见的并发病和多种药物增加了不良事件 (AE) 的风险,造成了可预防的伤害和医疗负担.
- 对ASD和ID患者来说,AE可能是造成伤害和不必要的医疗费用的重要来源.
研究的目的:
- 研究特定药物遗传标记对ASD和ID患者不良事件 (AE) 预防的影响.
- 为了确定潜在的遗传标记,可以预测或减轻与心理药物相关的AE的风险在这个脆弱的人群中.
主要方法:
- 在118名自闭症患者 (72名完成) 的横截面观察研究中.
- 数据收集包括社会人口统计学,精神药物使用和使用 Udvalg for Kliniske Undersøgelser (UKU) 规模识别的副作用.
- 在 *DOP2*, *ABCB1* 和 *COMT* 基因中的多态基因的基因定型,与AEs相关联. 一项文献审查确定了ASD成年人的相关药物和遗传标记.
主要成果:
- 研究群体主要包括患有多种并发症和多种药物的男性 (75%);抗精神病药物是最常见的药物 (69%).
- 21%的参与者经历了四次或更多的与精神药物相关的副作用,其中"神经"和"精神"副作用最常见 (41%).
- 在神经症状和*DOP2*基因型之间观察到显著的相关性,这表明等位基因变异影响AE发生.
结论:
- 确定了神经性AE和*DOP2*基因多态性之间的潜在关联,突出了其在改善ASD和ID患者处方安全方面的潜在作用.
- 用更大的样本大小进行进一步的研究是有必要的,以增加统计能力和增强人口代表性,以便得出可靠的结论.
- 研究*DOP2*基因多态可能有助于为患有ASD和ID的个人开更安全的精神药物处方.
相关概念视频
Human Genetics
588
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
588
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
167
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
167
Psychosis: Goals of Pharmacotherapy
145
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
145
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
696
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
696
Autism Spectrum Disorder
104
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
104
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47


